found COL6A1 expression was upregulated in cervical cancer tissues and high‐COL6A1 expression significantly correlated with advanced FIGO stage, larger tumor size, lymph node metastasis, and poorer overall and recurrence‐free survival in cervical cancer patients.43 Here, COL6A1 is linked to metastatic malignant neoplasm in the lymph nodes.